Autophagy reports

TFEB helps cells resist the chemotherapy drug CX-5461

Updated

Abstract

Gemcitabine causes and promotes protective signals through transcription factor EB ().

  • Gemcitabine disrupts DNA replication while also inducing nucleolar stress.
  • The anticancer agent CX-5461, which is designed to induce nucleolar stress, leads to TFEB accumulating in the nucleus.
  • Interfering with TFEB enhances the sensitivity of cancer cells to both CX-5461 and gemcitabine.
  • TFEB is associated with providing protective responses against stress from chemotherapeutic drugs.

Simplified

Key numbers

50%
Decrease in clonogenic growth ability
Observed in HeLa and MIA PaCa-2 cells with reduced levels.
60%
Clonogenic growth reduction at highest CX-5461 concentration
Measured in shTFEB cells compared to control at high CX-5461 doses.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

The authors have no potential conflict of interest to declare.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free